AKT1 and melanoma: Notably, the CHI3L1/IL-13R2 (its receptor) complex and transmembrane protein 219 (TMEM219) exacerbate lung damage, melanoma metastasis, and oxidant-induced apoptosis by activating the AKT pathway [27].